Advanex Inc.
15.10
EUR
0.00
(0.00%)
ISIN
JP3213400009
Return %
Stock
S&P 500
1Y
58.95
14.20
3Y
153.78
81.12
5Y
68.72
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Eitaro Asada
- Full Time Employees
- 1,913
- Sector
- Producer manufacturing
- Industry
- Metal fabrication
- Address
- Asuka Tower Tokyo TY Japan 114-8581
- IPO Date
- May 11, 1964
- Website
- advanex.co.jp
- Similar Companies
- Business
- Advanex Inc. is a Japan-based manufacturer specializing in precision springs and metal processing products, founded in 1946 and headquartered in Tokyo. The company offers a comprehensive range of core products including wire springs, flat springs, deep-drawn metal parts, insert moldings, spring assemblies, standard springs, CoilThread® inserts, hinges, LockOne anti-loosening products, and advanced sub-assemblies. Advanex serves diverse industries such as automotive, medical and pharmaceutical, aerospace and transport, infrastructure and building construction, consumer electronics, and office automation, providing engineering support from development through mass production. Its regional operations extend across Japan, the United States, Europe, Asia, and China. In recent developments, Advanex has expanded its manufacturing footprint and capabilities with new factory constructions in Chennai, India, and Czech Republic; it completed a major expansion at its Saitama factory in Japan. The company is enhancing precision spring manufacturing through the introduction of innovative machinery and technological advancements, including increased deep-drawing capabilities developed in partnership with the University of Nottingham. Advanex Americas committed an $11.4 million investment to expand its operations in Tennessee. Additionally, Advanex Medical has actively participated in global pharmaceutical industry events such as CPHI China 2024 and CPHI Barcelona 2023, signaling a strategic focus on expanding its pharmaceutical device segment. The company also received supplier awards from major clients and continues to forge partnerships to grow its global presence and product offerings. Advanex operates through four business segments centered on precision springs and related components, supplying high-quality, space-efficient, and technologically advanced products globally. The firm maintains a strong presence in the automotive sector while diversifying into medical devices, transport, infrastructure, and electronics markets. Its precision metal and plastic products leverage proprietary forming, deep drawing, and insert molding technologies, enabling tailored solutions for complex customer demands worldwide. The company employs approximately 1,870 people on a consolidated basis with consolidated net sales of around 28.5 billion yen for the fiscal year ending March 2025. Overall, Advanex Inc. stands as an established and technologically advanced global supplier of precision springs and metal products, with ongoing investments in manufacturing capacity and innovation to address expanding market needs across multiple industry sectors.